← SynDRA
C-1311
SynDRA canonical compound SYN0004481 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | FLT3 | HIF1A | TOP2A |
|---|
| Mechanism of action | anticancer agent |
|---|
All known targets
Mechanisms of action (all sources)
- FLT3 INHIBITOR
- Tyrosine-protein kinase receptor FLT3 inhibitor
- TOP2A INHIBITOR
- DNA topoisomerase II inhibitor
- TOP2B INHIBITOR
- NQO2 INHIBITOR
Drug classes
- Antineoplastic Agents
- Radiation-Sensitizing Agents
Cross-references
Synonyms
- C 1311
- Xls-002
- NSC-645809
- Symadex
- XF-02
- Imidacrine
- CHEMBL3545337
- XJYNBZQTAZDMHZ-UHFFFAOYSA-N
- Imidazoacridone dihydrocheloride hydrate
- 5-((2-(diethylamino)ethyl)amino)-8-hydroxy-6H-imidazo[4,5,1-de]acridin-6-one dihydrochloride hydrate
- XLS-002
- MZ4Y5H4OAB
- RefChem:122456
- DTXCID0082999
- C1311
- Imidazoacridinone
- Symadex free base
- CCRIS 7541
- UNII-MZ4Y5H4OAB
- Neuro_000342
- IMidazoacridone
- SCHEMBL2442405
- Symadex, >=98% (HPLC)
- SCHEMBL31238169
- CUNDRHORZHFPLY-UHFFFAOYSA-N
- NFA15439
- BDBM50008347
- NCGC00487207-01
- HY-10919
- NCI60_015698
- DB-316802
- (2-diethylaminoethylamino)-hydroxy-[?]one
- NSC645809
Look up C-1311 in the interactive SynDRA portal →